Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.

Status Completed

Clinical Trial Summary

Clinical trial of "line extension" of drug ARAFARMADOL® 0.075% cream in a new formulation in topical solution applicable in roll-on and with the same therapeutic indications approved for the cream.

Clinical Trial Description

The sponsor created a new pharmaceutical formulation of CAPSAICIN topical solution applicable in roll-on. This new formulation in roll-on represents a line extension of drug ARAFARMADOL 0.075 cream, which is currently marketed in Spain by the sponsor. The proposed investigational product as topical solution applicable in roll-on is expected to solve the compliance and safety issues of the cream with the same indications for use. Eligible patients will be randomized into two groups: CAPSAICIN topical solution applicable in roll-on and CAPSAICIN cream (ARAFARMADOL® ) for 8 weeks. Then, they will have a 4 week washout period and will be crossed over to the other treatment group for 8 weeks. A follow-up period of 2 weeks will take place after the end of both treatments. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05029297
Study type	Interventional
Source	Arafarma Group, S.A.
Contact
Status	Completed
Phase	Phase 3
Start date	November 4, 2010
Completion date	October 23, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04988321` - Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms	N/A
Completed	`NCT00385671` - An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain	Phase 4
Completed	`NCT00159679` - Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy	Phase 4
Completed	`NCT00141401` - Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.	Phase 3
Active, not recruiting	`NCT04469270` - Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT00553475` - Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT00381719` - Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy	Phase 2
Completed	`NCT00539175` - Treatment of Painful Diabetic Neuropathy With Photon Stimulation	N/A
Completed	`NCT00058968` - A Study for the Treatment of Painful Diabetic Neuropathy	Phase 3
Completed	`NCT02215252` - A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)	Phase 2
Completed	`NCT00785577` - A Study for Treatment of Pain in Patients With Diabetic Neuropathy.	Phase 2
Completed	`NCT00858351` - Thermal Biofeedback for the Treatment of Diabetic Neuropathy	N/A
Completed	`NCT03047278` - Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.	Phase 4
Completed	`NCT01628627` - Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy	Phase 4
Completed	`NCT03315598` - Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain	N/A
Completed	`NCT01057693` - Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT01564459` - Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)	Phase 2
Recruiting	`NCT01214590` - Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy	N/A
Completed	`NCT01089556` - A Study in Painful Diabetic Neuropathy	Phase 3
Completed	`NCT00501202` - Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).	Phase 2